| Clinical data | |
|---|---|
| Dependence liability | Moderate |
| Routes of administration | Oral, sublingual, rectal |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H13ClN4S |
| Molar mass | 328.82 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Metizolam (also known asdesmethyletizolam) is athienotriazolodiazepine that is the demethylatedanalogue of the closely relatedetizolam.[1][2][3][4][5][6]
Following its sale as adesigner drug,[7] metizolam was classified as controlled substance in Sweden on 26. January 2016.[8]